[Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate].
Arai
T
T
Dept. of Internal Medicine, Gihoku General Hospital.
Narimiya
S
S
Hayakawa
K
K
Takaya
T
T
Toshima
S
S
Araki
M
M
Uchida
A
A
Yoshimi
N
N
Shibuya
C
C
Yasuda
Y
Y
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001088:Arabinonucleotides / Q000627:therapeutic use*; D003568:Cytidine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D012074:Remission Induction
D000970:Antineoplastic Agents; D001088:Arabinonucleotides; C061162:1-arabinofuranosylcytosine-5'-stearylphosphate; D003568:Cytidine Monophosphate